Back to Journals » Therapeutics and Clinical Risk Management » Volume 16

Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach

Total article views   HTML views PDF downloads Totals
8,531 Dovepress* 7,583+ 1,357 8,940
PubMed Central* 948 288 1,236
Totals 8,531 1,645 10,176
*Since 22 July 2020
Total mentioned Facebook Delicious Reddit Twitter Others
7 0 0 0 1 6

View citations on PubMed Central and Google Scholar